US FDA’s Drug Center Losing Shortages, Controlled Substance Leadership With Throckmorton Retirement

Throckmorton is known for enhancing the FDA’s drug shortage work by building bridges between the compliance and quality teams, as well as opioid oversight.

Douglas Throckmorton will retire in January. (Shutterstock)

More from US FDA

More from Geography